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Abstract
Background: Reduced sleep quality is a common complaint among patients with chronic pain, with 50-80% of
patients reporting sleep disturbance. Improvements in pain and quality of life measures have been achieved using
a multidisciplinary cognitive behavioural therapy pain management programme (CBT-PMP) that aims to
recondition attitudes to pain, and improve patients’ self-management of their condition. Despite its high
prevalence in patients with chronic pain, there is very limited objective evidence for the effect of this intervention
on sleep quality. The primary research objective is to investigate the short-term effect of a multidisciplinary CBT-
PMP on subjective (measured by Pittsburg Sleep Quality Index) and objective sleep quality (measured by
Actigraphy) in patients with chronic pain by comparison with a control group. The secondary objectives will
investigate changes in function and mood, and then explore the relationship between objective and subjective
sleep quality and physical and psychological outcome measures.
Methods/Design: Patients who fulfil the inclusion criteria for attendance on the multidisciplinary CBT-PMP in the
Adelaide and Meath Hospital, Tallaght, Dublin and are currently listed on the PMP waiting list will be invited to
participate in this pilot study. Potential patients will be screened for sleep disturbance [determined by the
Pittsburgh Sleep Quality Index (PSQI)]. Those patients with a sleep disturbance (PSQI >5) will be assigned to either
the intervention group (immediate treatment), or control group (deferred treatment, i.e. the PMP they are listed for
is more than six months away) based on where they appear on the waiting list. Baseline measures of sleep,
function, and mood will be obtained using a combination of self-report questionnaires (the Hospital Anxiety and
Depression Scale, the Short Form 36 health survey, the Pittsburgh Sleep Quality Index, the Tampa Scale for
Kinesiophobia), and functional outcome measures. Sleep will be measured for seven days using actigraphy
(Actiwatch 7). These measures will be repeated after the four week multidisciplinary cognitive behavioural therapy
pain management programme, and at a two month follow-up. The waiting list control group will be assessed at
baseline, and two months later. Analysis for the primary outcome will include between group differences of
subjective and objective sleep parameters from baseline to follow-up using Independent T-tests or Mann-Whitney
U tests. The secondary outcomes establishing relationships between the sleep variables and physical and
psychological outcome measures will be established using multiple linear regression models.
Discussion: This pilot study will evaluate the impact of a multidisciplinary CBT-PMP on both subjective and
objective measures of sleep in patients with chronic pain and provide guidance for a larger clinical trial.
Trial Registration: Current controlled trial ISRCTN: ISRCTN74913595
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Chronic pain is a common disorder affecting 19% of the
European population. It has a detrimental effect on all
aspects of patient’s quality of life: physically, psychologi-
cally, and socially [1]. Reduced sleep quality is a com-
mon complaint in this patient cohort with 50-80%
reporting sleep disturbance [1,2]. Increasing evidence
suggests a deteriorating cycle of pain and sleep. Pain
can lead to poor sleep which in turn may result in
increased next day pain, leading to further problems
with next night sleep, as seen in other chronic pain con-
ditions such as burns and fibromyalgia [3-6]. Whether
cause or consequence, sleep disorders must be taken
into account in the overall management of the patient
in the same way as pain [7], as it has been hypothesized
that better daytime pain control may lead to improved
sleep quality [8]. Sleep disturbance has been shown to
have a number of negative effects on both physical and
psychological well-being. Physical effects include a
reduction of physical functioning, lowered immune
function, lower pain threshold [9], and an increase in
the release of pro-inflammatory cytokines [10-13]. Psy-
chologically, patient’s mental capacity to manage pain is
lowered, with increased risk of anxiety disorders and
alcohol abuse [14-16]. Depression is also strongly asso-
ciated with disturbed sleep patterns in this atient cohort
[17-19].
International best practice for the management of
chronic pain includes careful pharmacological manage-
ment, promotion of activity, and the provision of a cog-
nitive behavioural therapy pain management programme
(CBT PMP) [20]. This multi-disciplinary intervention
based on cognitive behavioural principles aimed at edu-
cating chronic pain patients on the physiology and psy-
chology of chronic pain, healthy functioning, and the
self-management of their pain problem. [21]. The pro-
gramme includes daily clinical psychology (cognitive
behavioural therapy, relaxation techniques), physiother-
apy (progressive gym exercise programme), and occupa-
tional therapy (improving occupational function and
environmental adaption).
The positive effect of this intervention on pain, dis-
ability, and mood has been established in two recent
systematic reviews [22,23]. However, despite the known
relationship between pain and sleep quality in this
patient cohort, the impact of CBT-PMPs on sleep is
limited. Significant positive changes in subjective sleep
disturbances have been reported, however sleep was not
the primary outcome measure, and no specific validated
subjective or objective sleep quality measures were used
[24]. A second study using both objective (actigraphy)
and subjective outcome measures (PSQI) did report sig-
nificant differences in sleep quality pre and post CBT
PMP and at a three-month follow-up (P < 0.05) [25].
However, the main conclusions were drawn from the
subjective data only. More recently a randomised con-
trolled trial of individual cognitive behavioural therapy
intervention for insomnia, delivered by a psychologist,
demonstrated significant improvement in subjective and
objective sleep indices for patients with chronic neck
and back pain [26]. Drawing conclusions from subjective
sleep quality outcome measures is limiting; objective and
subjective sleep measures only correlate modestly with
each other, therefore both should be included [27-30].
Due to the limited objective evidence to date, this
pilot study will determine the short-term impact of a
CBT-PMP on changes in objective and subjective sleep
quality measures, as well as the impact of these changes
on patient’s psychological and physical measures.
Method/Design
Research Objectives
The primary research objective is to investigate the
short-term multidisciplinary CBT-PMP on subjective
(measured by PSQI) and objective sleep quality (mea-
sured by Actigraphy) in patients with chronic pain by
comparison with a control group. The secondary objec-
tive will investigate changes in function and mood, and
then explore the relationship between objective and sub-
jective sleep quality, and physical and psychological out-
come measures.
Ethical Approval
This study was granted ethical approval from the Ade-
laide and Meath Hospital, Incorporating the National
Children’s Hospital Healthcare Group, Ethics and Medi-
cal Research Committee in October 2007.
Study Design
This study is a longitudinal pilot study, with patients
recruited from the adult Pain service in the Adelaide
and Meath Hospital, Dublin (Figure 1). Potential
patients who fulfil the inclusion criteria for participation
on the multidisciplinary CBT-PMP will be invited to
participate in the study by the principle investigator
(PI). The study protocol will be reviewed with potential
participants, and all questions answered regarding the
study. One week later, following a cooling off period,
written consent will be obtained, and participants will
complete the Pittsburgh Sleep Quality Index (PSQI).
Those patients with a sleep disturbance (PSQI >5) will
be assigned to either the intervention group (immediate
treatment), or control group (deferred treatment, i.e. the
P M Pt h e ya r el i s t e df o ri sm o r et h a ns i xm o n t h sa w a y )
based on where they appear on the waiting list. Group
membership will be concealed from the PI. To be
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the following criteria:
Inclusion Criteria
￿ Deemed suitable for the AMNCH multidisciplinary
CBT-PMP as per the multidisciplinary pain team
￿ Willing to participate in the study
￿ > 18 years old
￿ Suffering from sleep disturbance due to pain as
determined by the PSQI questionnaire
























Figure 1 Study Protocol.
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￿ Deemed unsuitable for the AMNCH multidisci-
plinary CBT-PMP as per the multidisciplinary pain
team
￿ Unwilling to take part in the study
￿ <18 years old
￿ D on o ts u f f e rf r o ms l e e pd i s t u r b a n c ed u et op a i n
as determined by the PSQI questionnaire (a score >5
indicating sleep disturbance)
Intervention
A multi-disciplinary CBT-PMP provides the patient with
multiple therapies involving comprehensive rehabilita-
tion in each of the specialized areas [31]. The core
multi-disciplinary team includes a pain management
physician, an occupational therapist, a physiotherapist
and a clinical psychologist. They identify and change
unhelpful thoughts and beliefs; promote relaxation, and
help to change habits that contribute to disability
[21,22].The multi-disciplinary team focuses on specific
achievable goals established between the individual
therapist and the patient [32]. Participants are advised
to practice the skills they have learned both at home,
and in other environments, integrating them into their
everyday lives in order to help them to manage their
pain more effectively [21].
Participants will attend three days a week for four
consecutive weeks. The multidisciplinary programme
includes daily two-hour group sessions with physiother-
apy (stretching programme, core stability strengthening
programme, paced individual exercise on a range of gym
equipment, and functional restoration), occupational
therapy (improving occupational function and environ-
mental adaption), and clinical psychology (cognitive
behavioural therapy, relaxation techniques). Weekly edu-
cation sessions with the Pain consultant are also held.
Assessment
A combination of valid and reliable self-report measures
of pain, sleep quality, quality of life, nd mood, as well as
objective measures of function and sleep will be used.
Study Patients
One week prior to the commencement of the multidis-
ciplinary CBT-PMP patients will be given an appoint-
ment with the PI to obtain baseline measures. This will
involve completing the self-report questionnaires and
undergoing the physical tests. Patients will be instructed
to wear the Actiwatch for seven days (24 hours a day),
and to complete the Pittsburgh Sleep diary (PghSD) dur-
ing this time. Following the four week CBT-PMP the
patients will be reassessed, given the Actiwatch to wear
for seven days, and complete the sleep diary. Two
months later, one week prior to the appointment date
patients will be sent (by registered post) the Actiwatch
to wear for seven days, and the PghSD to complete.
During the appointment patients will repeat the battery
of self-report and functional tests.
Control Group
Patients will undergo the same assessment procedures at
baseline and three months later.
Instrumentation and Measurements
The instrumentation and measurement tools will
include:
Self reported outcome measures
Numerical Rating Scale (NRS) This 11-point scale (0-
10 where 0 is no pain at all, and 10 is the worst pain
imaginable) is ommonly used in the assessment of pain
[33], and is a core outcome measure in clinical rials of
chronic pain patients [34,35].
Tampa Scale for Kinesiophobia (TSK-II) This scale
measures the degree of fear of movement and/or re-
injury, and is commonly used in acute and chronic pain
populations [36]. It consists of an 11-item self-report
questionnaire scored on a four-point Likert scale. The
TSK-II consists of two subscales; a somatic focus sub-
s c a l e( i t e m s3 ,4 ,6 ,7 ,a n d1 0 )t h a tr e f l e c tt h eb e l i e f s
that there is something seriously wrong with the body,
and an activity avoidance subscale (items 1, 2, 5, 8, 9,
and 11) that reflects the beliefs that avoiding exercise or
physical activities might prevent an increase of pain. A
reduction of at least four points on both measures maxi-
mises the likelihood of correctly identifying an impor-
tant reduction in fear of movement. The reliability of
the TSK-11 has been established [36].
SF-36 Health Survey This tool will be used to measure
health related quality of life (HRQL) and physical func-
tioning [37]. It consists of 36 items that measures 8
multi-item variables including physical functioning,
social functioning, role limitations due to physical
problem, mental health, energy and vitality, pain and
general perception of health, there is also one extra
un-scaled item to assess a patient’s perceived change in
health in the last year. The SF36 is a validated and reli-
able tool with a high internal reliability value across all
items >0.7 except those in the social dimension which
were found to be >0.5 [38,39]
The Hospital Anxiety and Depression Scale (HADS)
This questionnaire will be used to assess a patient’s level
of anxiety and depression. It is divided into two sub-
scales; an anxiety subscale (HAD-A) and a depression
subscale (HADS-D). Both subscales contain 7 inter-
mingled items. Scores of 11 or more on either subscale
are considered to represent a significant case of psycho-
logical morbidity, scores of 8-10 represents borderline
psychological morbidity and scores of 0-7 represent nor-
mal levels of anxiety and/or depression [40]. The HADS
has high mean levels of internal consistency HAD-A
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tivity and specificity of 0.8 for both HAD (A) and HAD
(D)[41].
Pittsburgh Sleep Diary (PghSD) This tool will be used
as an adjunct for the Actiwatch AW7 to give a written
recording for the objective Actiwatch data. It will be
filled in every day for the 7 days that the patient wears
the Actiwatch. The instrument comprises two separate
sections; a bedtime component that will be filled in just
before bed, and a wake time component that will be
filled in first thing in the morning. The bedtime compo-
nent documents events preceding that nights’ sleep that
may have an impact on sleep quality or quantity; the
number of caffeinated drinks consumed, or the number
of daytime naps. The wake time component documents
events that occur during the night that may impact on
that night’s sleep such as the number of wake bouts
during the night, and patient satisfaction of sleep qual-
ity. The PghSD measures of both sleep timing and sleep
quality has been shown to have correlations between
0.56 and 0.81 (n = 39, P < 0.001) [42].
Sleep
Sleep
Objective sleep quality will be measured using the Acti-
watch AW7 (Cambridge Neurotechnology). Whist not
as accurate as the gold standard of sleep assessment,
actigraphy has been shown to correlate reasonably well
with polysomnography; with intraclass correlation co-
efficient of 0.76 for total sleep time, 0.61 for sleep effi-
ciency, and 0.58 for both wake after sleep onset and
sleep fragmentation index measurements [43]. This
compact and lightweight electronic device similar in size
to a wrist-watch is worn on the non-dominant hand,
and measures and records physical movement. It auto-
matically collects and scores data for seven sleep quality
parameters: wake after sleep onset percentage, sleep
onset latency, actual sleep percentage, mean night-time
activity, fragmentation index, number of wake bouts,
and sleep efficiency. This movement data is then down
loaded and analysed using Actiwatch 7 software. Activity
is measured in counts; the number of counts is propor-
tional to the intensity of the movement. The peak inten-
sity of the movement in each second is summed into a
user selectable epoch (range two seconds and 15 min-
utes). Data collected is more accurate with a shorter
epoch length [44]. The current study proposes to record
data for 7 days using a 30 second epoch length, which
has been shown to be adequate for the assessment of
sleep disturbance [44].
When a patient is ready to sleep they will press the
button on the actiwatch to signal this intention of sleep
start. When the patient wakes they will press the button
a second time to indicate that sleep has finished, this
defines the sleep period for analysis. If a patient forgets
to press the button, the Pittsburgh sleep diary will be
used to determine the sleep start and/or finish. The acti-
watch 7 sleep software can then determine the objective
sleep quality outcome measures: wake after sleep onset
percentage, sleep onset latency, actual sleep percentage,
mean night-time activity, fragmentation index, number
of wake bouts, and sleep efficiency.
Function
The Simmond’s functional assessment tool [45] is a vali-
dated battery of physical performance measures
designed to assess function in patients with chronic
LBP. For the purpose of the current study two of these
physical performance measures will be included. The
sit-to-stand test (STS) times patients as they get up and
down out of a chair five times, repeated twice, and the
mean time is recorded. The 360° rollover tests times the
patient rolling 360 degrees. The Simmond’sb a t t e r yo f
tests has been found to have good validity and reliability
of between 0.69 and 0.99, with a construct validity of
P < 0.0001 [46].
Data management
All participant data will be coded to ensure anonymity,
and stored in a password protected computer, and ques-
tionnaires locked in a filing cabinet at the School of
Public Health, Physiotherapy and Population Science,
University College Dublin, Ireland.
Sample size/Power calculation
While formal power based calculations are not be neces-
sary for a pilot trial, sample estimates to guide recruit-
ment to this study were based on existing data, using
objective sleep disturbance as the primary outcome
measure. Actigraphy data from patients with chronic
LBP [47] indicated that sleep efficiency percentage
(mean = 77.8, Sd 7.8) was the variable which differed
most significantly from controls. On this basis, a mini-
mum of 90 subjects will be required to detect a moder-
ate treatment effect (ES 0.6). For the purposes of
establishing feasibility, and providing data to inform the
design of a future main trial based on our CBT-PMP
population, we however aim to recruit 24 patients for
each arm of the pilot study.
Data Analysis
All data will be cleaned and entered into the Statistical
Package for the Social Sciences (SPSS, Version 16) for
analysis. Baseline and demographic data will be pre-
sented using descriptive statistics. Differences from base-
line will be calculated for all primary and secondary
outcomes. Mean differences, standard deviations and
95% confidence intervals will be calculated for continu-
ous variables. Data will be tested for assumptions of
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where this is shown. Non-parametric tests will be per-
formed on all ordinal and non-normally distributed
data. All tests will be 2 sided with a critical value of
p < 0.05.
Primary Outcome: Between group differences in
changes to the primary outcome (objective and self-
report sleep measures) from baseline to follow up will
be performed with independent t tests or Mann Whit-
ney U tests. An intention to treat analysis will also be
performed, where missing data are estimated using
regression based multiple imputation methods.
Secondary Outcomes: To establish relationships
between the sleep variables and other outcome measures
(physical and psychological), multiple linear regression
models will be constructed. Univariate regression will
first be performed and those variables shown to be asso-
ciated with the dependent variable will be included in
the multivariate model. Backward regression will be
used to determine the model of best fit.
Discussion
This pilot study will determine the impact of a multidis-
ciplinary CBT-PMP on objective and self-report sleep
quality in patients with chronic pain. It will also investi-
gate the relationship between sleep variables and physi-
cal and psychological outcome measures. These results
will add to the knowledge of the impact of a multidisci-
plinary CBT-PMP on patient’s quality of life.
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